Kelvin Cooper
Chief Executive Officer, Lakewood-Amedex Biotherapeutics Inc.
Companies
- Lakewood-Amedex Biotherapeutics Inc.Board member May 1, 2026 to now1
- Lakewood-Amedex Biotherapeutics Inc.Chief executive officer May 1, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lakewood-Amedex Biotherapeutics Inc. LABT300,594 shares2$174.2K at $0.58May 1, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2